The Diabetes Partnering provides understanding and access to the diabetes partnering deals and agreements entered into by the worlds leading healthcare companies
Bayer, a top pharma company is considering the sale of its blood glucose meters business as it offers few synergies with its other healthcare activities
Proteonomix has that it has decided to examine the possibility of licensing its stem cell diabetes related technology to another company in light of continued progress toward its trial of UMK-121, its stem cell treatment for patients awaiting liver transplant to overcome End Stage Liver Disease (“ESLD”).
The Global Autoimmune Disease Partnering 2010-2015 report provides comprehensive understanding and unprecedented access to the autoimmune partnering deals and agreements entered into by the worlds leading healthcare companies
Merger news: Rumors that Ireland-based Actavis is still looking to buy up a company or two continue with speculation that it is considering Spanish drugmaker Almirall SA. Actavis, which is domiciled in Ireland, but operates out of Parsippany, N.J. was also earlier rumored to be interested in buying GI drugmaker Salix Pharmaceuticals and Omega Pharma NV.
Sorry, your search returned no results.
Eli, Lilly and Company pharma partners on a five-year research partnership with the University of Surrey to study health outcomes, focusing on the effects of treatment in people with type 2 diabetes, which affects about 95 percent of those with the disease.
Intarcia Therapeutics announced the successful start of a strategic partnership with Servier outside the United States and Japan, to develop and commercialize ITCA 650
Zosano Pharma has entered into a pharma deal with Novo Nordisk to develop a new transdermal presentation of semaglutide for $155 million.
Tandem Diabetes Care is plotting a trip to Wall Street, filing to raise $100 million in an IPO financing and join the bevy of biotech companies cashing in on a market revival